Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.02 EUR
−9.76 M EUR
226.91 M EUR
666.53 M
About PHARMING GROUP
Sector
CEO
Sijmen de Vries
Headquarters
Leiden
Website
Founded
2019
ISIN
NL0010391025
FIGI
BBG000BM1P47
Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following segments: RUCONEST®, Joenja®, Europe, and Rest of the World. The company was founded on November 11, 1988, and is headquartered in Leiden, the Netherlands.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PHGN is 0.95 EUR — it has increased by 6.74% in the past 24 hours. Watch PHARMING GROUP NV stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange PHARMING GROUP NV stocks are traded under the ticker PHGN.
PHGN stock has risen by 12.23% compared to the previous week, the month change is a 36.40% rise, over the last year PHARMING GROUP NV has showed a −9.44% decrease.
We've gathered analysts' opinions on PHARMING GROUP NV future price: according to them, PHGN price has a max estimate of 3.57 EUR and a min estimate of 1.42 EUR. Watch PHGN chart and read a more detailed PHARMING GROUP NV stock forecast: see what analysts think of PHARMING GROUP NV and suggest that you do with its stocks.
PHGN reached its all-time high on Dec 20, 2019 with the price of 1.63 EUR, and its all-time low was 0.04 EUR and was reached on Apr 25, 2013. View more price dynamics on PHGN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
PHGN stock is 6.86% volatile and has beta coefficient of 1.21. Track PHARMING GROUP NV stock price on the chart and check out the list of the most volatile stocks — is PHARMING GROUP NV there?
Today PHARMING GROUP NV has the market capitalization of 605.77 M, it has increased by 7.92% over the last week.
Yes, you can track PHARMING GROUP NV financials in yearly and quarterly reports right on TradingView.
PHARMING GROUP NV is going to release the next earnings report on Mar 13, 2025. Keep track of upcoming events with our Earnings Calendar.
PHGN earnings for the last quarter are 0.00 EUR per share, whereas the estimation was 0.00 EUR resulting in a −700.00% surprise. The estimated earnings for the next quarter are 0.00 EUR per share. See more details about PHARMING GROUP NV earnings.
PHARMING GROUP NV revenue for the last quarter amounts to 67.23 M EUR, despite the estimated figure of 69.09 M EUR. In the next quarter, revenue is expected to reach 77.96 M EUR.
PHGN net income for the last quarter is −941.24 K EUR, while the quarter before that showed −1.11 M EUR of net income which accounts for 15.56% change. Track more PHARMING GROUP NV financial stats to get the full picture.
No, PHGN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PHARMING GROUP NV EBITDA is −5.34 M EUR, and current EBITDA margin is −4.49%. See more stats in PHARMING GROUP NV financial statements.
Like other stocks, PHGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHARMING GROUP NV stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHARMING GROUP NV technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHARMING GROUP NV stock shows the buy signal. See more of PHARMING GROUP NV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.